- PPD Named “Best CRO” at Vaccine Industry Excellence Awards
- PPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing Capabilities
- PPD Reports First Quarter 2021 Results
- PPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate Development
- Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
- PPD Announces First Quarter 2021 Earnings Conference Call
- PPD and Clinical Ink Collaborate on Innovative Process for Lupus Assessment and Near Real-Time Access to Endpoint Data
- PPD Named a Leader in Digital Clinical Trial Solutions by ISG
- PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day
- PPD to Present at Barclays Global Healthcare Conference
PPD Inc (PPD:NSQ) closed at 46.12, -0.80% below its 52-week high of 46.49, set on Apr 19, 2021.
24.75Jun 11 202046.49Apr 19 2021
Markit short selling activity
|Market cap||16.18bn USD|
|EPS (TTM)||0.3380 |
Data delayed at least 15 minutes, as of May 10 2021 21:00 BST.